DD300132A5 - Einrichtung und verfahren zum nachweisen und messen der konzentration von substanzen in einer probe durch optoakustische spektroskopie - Google Patents

Einrichtung und verfahren zum nachweisen und messen der konzentration von substanzen in einer probe durch optoakustische spektroskopie Download PDF

Info

Publication number: DD300132A5
Authority: DD; German Democratic Republic
Prior art keywords: sample; light; substance; light source; acoustic
Prior art date: 1987-03-03

Application number

DD88313361A

Other languages

German (de)

English (en)

Inventor

Elizabeth M Dowling

Original Assignee

Dowling Elizabeth May

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-03-03

Filing date

1988-03-03

Publication date

1992-05-21

1988-03-03 Application filed by Dowling Elizabeth May filed Critical Dowling Elizabeth May

1992-05-21 Publication of DD300132A5 publication Critical patent/DD300132A5/de

Links

239000000126 substance Substances 0.000 title claims abstract description 93
238000000034 method Methods 0.000 title claims abstract description 30
238000004611 spectroscopical analysis Methods 0.000 title description 4
238000004867 photoacoustic spectroscopy Methods 0.000 claims abstract description 31
230000004044 response Effects 0.000 claims abstract description 18
238000001228 spectrum Methods 0.000 claims abstract description 11
238000001727 in vivo Methods 0.000 claims abstract description 8
238000005259 measurement Methods 0.000 claims description 35
238000012545 processing Methods 0.000 claims description 18
239000004065 semiconductor Substances 0.000 claims description 16
238000011835 investigation Methods 0.000 claims description 10
241001465754 Metazoa Species 0.000 claims description 8
230000005284 excitation Effects 0.000 claims description 8
238000005286 illumination Methods 0.000 claims description 7
210000001124 body fluid Anatomy 0.000 claims description 5
239000010839 body fluid Substances 0.000 claims description 5
238000006243 chemical reaction Methods 0.000 claims description 4
238000012623 in vivo measurement Methods 0.000 claims description 4
238000002834 transmittance Methods 0.000 claims description 4
238000000862 absorption spectrum Methods 0.000 claims description 3
230000005534 acoustic noise Effects 0.000 claims description 2
230000005540 biological transmission Effects 0.000 claims description 2
230000008569 process Effects 0.000 abstract description 9
238000000338 in vitro Methods 0.000 abstract description 7
238000010924 continuous production Methods 0.000 abstract description 4
239000000523 sample Substances 0.000 description 63
239000008280 blood Substances 0.000 description 27
210000004369 blood Anatomy 0.000 description 27
239000012530 fluid Substances 0.000 description 11
238000004519 manufacturing process Methods 0.000 description 9
238000004458 analytical method Methods 0.000 description 8
239000007788 liquid Substances 0.000 description 8
238000012360 testing method Methods 0.000 description 8
210000002700 urine Anatomy 0.000 description 6
239000003153 chemical reaction reagent Substances 0.000 description 5
229940079593 drug Drugs 0.000 description 5
239000003814 drug Substances 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
238000012544 monitoring process Methods 0.000 description 5
238000003556 assay Methods 0.000 description 4
238000009534 blood test Methods 0.000 description 4
239000000306 component Substances 0.000 description 4
239000000356 contaminant Substances 0.000 description 4
230000001419 dependent effect Effects 0.000 description 4
238000001514 detection method Methods 0.000 description 4
238000003745 diagnosis Methods 0.000 description 4
201000010099 disease Diseases 0.000 description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
230000000694 effects Effects 0.000 description 4
239000007789 gas Substances 0.000 description 4
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
230000008901 benefit Effects 0.000 description 3
206010012601 diabetes mellitus Diseases 0.000 description 3
239000000835 fiber Substances 0.000 description 3
239000008103 glucose Substances 0.000 description 3
239000002184 metal Substances 0.000 description 3
229910052751 metal Inorganic materials 0.000 description 3
150000002739 metals Chemical class 0.000 description 3
230000035515 penetration Effects 0.000 description 3
239000000243 solution Substances 0.000 description 3
208000030507 AIDS Diseases 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
239000012503 blood component Substances 0.000 description 2
230000036772 blood pressure Effects 0.000 description 2
210000001185 bone marrow Anatomy 0.000 description 2
230000008859 change Effects 0.000 description 2
238000009792 diffusion process Methods 0.000 description 2
239000003344 environmental pollutant Substances 0.000 description 2
230000001815 facial effect Effects 0.000 description 2
238000010304 firing Methods 0.000 description 2
235000013305 food Nutrition 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
238000002483 medication Methods 0.000 description 2
239000003921 oil Substances 0.000 description 2
230000001575 pathological effect Effects 0.000 description 2
230000007170 pathology Effects 0.000 description 2
231100000719 pollutant Toxicity 0.000 description 2
238000002310 reflectometry Methods 0.000 description 2
238000005070 sampling Methods 0.000 description 2
230000028327 secretion Effects 0.000 description 2
238000007493 shaping process Methods 0.000 description 2
239000000725 suspension Substances 0.000 description 2
239000003053 toxin Substances 0.000 description 2
231100000765 toxin Toxicity 0.000 description 2
108700012359 toxins Proteins 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
206010068150 Acoustic shock Diseases 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
208000030852 Parasitic disease Diseases 0.000 description 1
241000097929 Porphyria Species 0.000 description 1
208000010642 Porphyrias Diseases 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000009471 action Effects 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
235000013405 beer Nutrition 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
230000036760 body temperature Effects 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
230000001914 calming effect Effects 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
238000001311 chemical methods and process Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000009535 clinical urine test Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
238000013479 data entry Methods 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000012467 final product Substances 0.000 description 1
239000005417 food ingredient Substances 0.000 description 1
230000006870 function Effects 0.000 description 1
230000005484 gravity Effects 0.000 description 1
231100001261 hazardous Toxicity 0.000 description 1
230000036541 health Effects 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
239000012535 impurity Substances 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000007689 inspection Methods 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
230000031700 light absorption Effects 0.000 description 1
235000021056 liquid food Nutrition 0.000 description 1
239000000463 material Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
239000000203 mixture Substances 0.000 description 1
239000002245 particle Substances 0.000 description 1
239000000575 pesticide Substances 0.000 description 1
239000003209 petroleum derivative Substances 0.000 description 1
239000000047 product Substances 0.000 description 1
238000011002 quantification Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000012216 screening Methods 0.000 description 1
230000035939 shock Effects 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000012265 solid product Substances 0.000 description 1
241000894007 species Species 0.000 description 1
238000012306 spectroscopic technique Methods 0.000 description 1
210000000278 spinal cord Anatomy 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
239000013076 target substance Substances 0.000 description 1
210000001138 tear Anatomy 0.000 description 1
238000010998 test method Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
230000002463 transducing effect Effects 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/1702—Systems in which incident light is modified in accordance with the properties of the material investigated with opto-acoustic detection, e.g. for gases or analysing solids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0093—Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy
- A61B5/0095—Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy by applying light and detecting acoustic waves, i.e. photoacoustic measurements
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/417—Evaluating particular organs or parts of the immune or lymphatic systems the bone marrow

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Physics & Mathematics (AREA)
Pathology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Medical Informatics (AREA)
Molecular Biology (AREA)
Surgery (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Immunology (AREA)
Analytical Chemistry (AREA)
Optics & Photonics (AREA)
Chemical & Material Sciences (AREA)
Biochemistry (AREA)
General Physics & Mathematics (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Spectroscopy & Molecular Physics (AREA)
Emergency Medicine (AREA)
Acoustics & Sound (AREA)
Investigating Or Analysing Materials By Optical Means (AREA)
Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)

DD88313361A 1987-03-03 1988-03-03 Einrichtung und verfahren zum nachweisen und messen der konzentration von substanzen in einer probe durch optoakustische spektroskopie DD300132A5 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AU6966087		1987-03-03
AUPI611587		1987-12-29

Publications (1)

Publication Number	Publication Date
DD300132A5 true DD300132A5 (de)	1992-05-21

Family

ID=25636014

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD88313361A DD300132A5 (de)	1987-03-03	1988-03-03	Einrichtung und verfahren zum nachweisen und messen der konzentration von substanzen in einer probe durch optoakustische spektroskopie

Country Status (9)

Country	Link
EP (1)	EP0282234A1 (da)
KR (1)	KR880011584A (da)
CN (1)	CN1032587A (da)
DD (1)	DD300132A5 (da)
DK (1)	DK111088A (da)
FI (1)	FI880969A7 (da)
IL (1)	IL85611A0 (da)
NO (1)	NO880891L (da)
PL (1)	PL270977A1 (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102021004609A1 (de)	2021-09-11	2023-03-16	Eques Consulting GmbH	Vorrichtung und damit durchführbares Verfahren zur non-invasiven Konzentrationsbestimmung von Komponenten im menschlichen Blutkreislauf und Verwendung des Verfahrens.

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1331483C (en) *	1988-11-02	1994-08-16	Britton Chance	User-wearable hemoglobinometer for measuring the metabolic condition of a subject
US5873821A (en) *	1992-05-18	1999-02-23	Non-Invasive Technology, Inc.	Lateralization spectrophotometer
GB8922909D0 (en) *	1989-10-11	1989-11-29	Varilab Ab	Assay method
US5246004A (en) *	1990-02-02	1993-09-21	Angiomedics Ii, Inc.	Infrared cholesterol sensor
US5222496A (en) *	1990-02-02	1993-06-29	Angiomedics Ii, Inc.	Infrared glucose sensor
US5222495A (en) *	1990-02-02	1993-06-29	Angiomedics Ii, Inc.	Non-invasive blood analysis by near infrared absorption measurements using two closely spaced wavelengths
US5239180A (en) *	1990-02-02	1993-08-24	Boston Advnaced Technologies, Inc.	Laser systems for food analysis based on reflectance ratio detection
WO1991011136A1 (en) *	1990-02-02	1991-08-08	Boston Advanced Technologies, Inc.	Systems for material analysis based on reflectance ratio detection
US6549795B1 (en)	1991-05-16	2003-04-15	Non-Invasive Technology, Inc.	Spectrophotometer for tissue examination
AU1364292A (en) *	1992-02-28	1993-09-13	Theodore E. Cadell	Non-invasive device and method for determining concentrations of various components of blood or tissue
US5954053A (en) *	1995-06-06	1999-09-21	Non-Invasive Technology, Inc.	Detection of brain hematoma
US6785568B2 (en)	1992-05-18	2004-08-31	Non-Invasive Technology Inc.	Transcranial examination of the brain
GB2271181A (en) *	1992-09-30	1994-04-06	Marconi Gec Ltd	Photoacoustic Gas Analyser.
DE4242232C2 (de) *	1992-12-15	1998-12-10	Burkhard Kuhls	Vorrichtung und Verfahren zur nicht-invasiven Konzentrationsbestimmung polarisierender Stoffe im menschlichen Körper
US5752512A (en) *	1995-05-10	1998-05-19	Massachusetts Institute Of Technology	Apparatus and method for non-invasive blood analyte measurement
US5840023A (en) *	1996-01-31	1998-11-24	Oraevsky; Alexander A.	Optoacoustic imaging for medical diagnosis
DE19632867B4 (de) *	1996-08-14	2006-07-27	Columbus Schleif- Und Zerspantechnik Hard- Und Softwaresysteme Gmbh	Meßkopf für die photoakustische Spektroskopie
DE29617790U1 (de) *	1996-10-02	1997-01-02	Institut für Bioprozeß- und Analysenmeßtechnik e.V., 37308 Heilbad Heiligenstadt	Offene photoakustische Meßzelle
GB9704737D0 (en)	1997-03-07	1997-04-23	Optel Instr Limited	Biological measurement system
GB2357844A (en) *	1997-03-07	2001-07-04	Optel Instr Ltd	Normalising a photoacoustic signal in a biological measurement system
US5941821A (en) *	1997-11-25	1999-08-24	Trw Inc.	Method and apparatus for noninvasive measurement of blood glucose by photoacoustics
WO1999040840A1 (en)	1998-02-11	1999-08-19	Non-Invasive Technology, Inc.	Detection, imaging and characterization of breast tumors
CA2319456C (en)	1998-02-11	2011-01-04	Non-Invasive Technology, Inc.	Imaging and characterization of brain tissue
FR2775344B1 (fr) *	1998-02-20	2000-05-12	Compucal	Dispositif de mesure de concentration moleculaire sans intrusion dans des produits tels que des fruits et legumes
GB9822270D0 (en) *	1998-10-13	1998-12-09	Payne Peter A	Ophthalmic methods
JP3594534B2 (ja)	1999-04-30	2004-12-02	ヘルマンファウ、リリエンフェルトアル	物質を検出する装置
WO2001010295A1 (en) *	1999-08-06	2001-02-15	The Board Of Regents Of The University Of Texas System	Optoacoustic monitoring of blood oxygenation
US6751490B2 (en)	2000-03-01	2004-06-15	The Board Of Regents Of The University Of Texas System	Continuous optoacoustic monitoring of hemoglobin concentration and hematocrit
US6652459B2 (en)	2000-06-28	2003-11-25	Peter Alfred Payne	Ophthalmic uses of lasers
IL138073A0 (en)	2000-08-24	2001-10-31	Glucon Inc	Photoacoustic assay and imaging system
KR100493154B1 (ko)	2002-03-20	2005-06-03	삼성전자주식회사	광음향분광학을 이용한 비침습적 생체성분 측정장치
AUPS332802A0 (en) *	2002-07-03	2002-07-25	Iwrx Pty Ltd	Sucrose monitor
US7356365B2 (en)	2003-07-09	2008-04-08	Glucolight Corporation	Method and apparatus for tissue oximetry
US7020506B2 (en)	2003-11-06	2006-03-28	Orsense Ltd.	Method and system for non-invasive determination of blood-related parameters
WO2005067786A1 (en) *	2004-01-15	2005-07-28	Glucon Inc.	Wearable glucometer
US7510849B2 (en)	2004-01-29	2009-03-31	Glucolight Corporation	OCT based method for diagnosis and therapy
US8036727B2 (en)	2004-08-11	2011-10-11	Glt Acquisition Corp.	Methods for noninvasively measuring analyte levels in a subject
US7254429B2 (en)	2004-08-11	2007-08-07	Glucolight Corporation	Method and apparatus for monitoring glucose levels in a biological tissue
JP2008537903A (ja)	2005-04-13	2008-10-02	グルコライト・コーポレーシヨン	Ｏｃｔが基になった血糖モニターのデータ処理および較正方法
DE102007014516B4 (de)	2007-03-27	2008-12-04	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Verfahren und Vorrichtung zur Messung des photoakustischen Signals mit rechnergestützter Auswertung
US8571617B2 (en)	2008-03-04	2013-10-29	Glt Acquisition Corp.	Flowometry in optical coherence tomography for analyte level estimation
US9289191B2 (en)	2011-10-12	2016-03-22	Seno Medical Instruments, Inc.	System and method for acquiring optoacoustic data and producing parametric maps thereof
US20130109950A1 (en) *	2011-11-02	2013-05-02	Seno Medical Instruments, Inc.	Handheld optoacoustic probe
US8686335B2 (en)	2011-12-31	2014-04-01	Seno Medical Instruments, Inc.	System and method for adjusting the light output of an optoacoustic imaging system
JP5677044B2 (ja) *	2010-11-19	2015-02-25	キヤノン株式会社	光音響測定装置及び方法
CN103458816B (zh) *	2011-03-29	2017-05-10	皇家飞利浦有限公司	基于功能成像的消融监测
US9055869B2 (en)	2011-10-28	2015-06-16	Covidien Lp	Methods and systems for photoacoustic signal processing
US9743839B2 (en)	2011-11-02	2017-08-29	Seno Medical Instruments, Inc.	Playback mode in an optoacoustic imaging system
US9730587B2 (en)	2011-11-02	2017-08-15	Seno Medical Instruments, Inc.	Diagnostic simulator
US20130116538A1 (en)	2011-11-02	2013-05-09	Seno Medical Instruments, Inc.	Optoacoustic imaging systems and methods with enhanced safety
US9814394B2 (en)	2011-11-02	2017-11-14	Seno Medical Instruments, Inc.	Noise suppression in an optoacoustic system
US9445786B2 (en)	2011-11-02	2016-09-20	Seno Medical Instruments, Inc.	Interframe energy normalization in an optoacoustic imaging system
US20130338475A1 (en)	2012-06-13	2013-12-19	Seno Medical Instruments, Inc.	Optoacoustic imaging system with fiber optic cable
US11287309B2 (en)	2011-11-02	2022-03-29	Seno Medical Instruments, Inc.	Optoacoustic component utilization tracking
US20130289381A1 (en)	2011-11-02	2013-10-31	Seno Medical Instruments, Inc.	Dual modality imaging system for coregistered functional and anatomical mapping
US9757092B2 (en)	2011-11-02	2017-09-12	Seno Medical Instruments, Inc.	Method for dual modality optoacoustic imaging
US9733119B2 (en)	2011-11-02	2017-08-15	Seno Medical Instruments, Inc.	Optoacoustic component utilization tracking
US11191435B2 (en)	2013-01-22	2021-12-07	Seno Medical Instruments, Inc.	Probe with optoacoustic isolator
US10433732B2 (en)	2011-11-02	2019-10-08	Seno Medical Instruments, Inc.	Optoacoustic imaging system having handheld probe utilizing optically reflective material
US20140005544A1 (en)	2011-11-02	2014-01-02	Seno Medical Instruments, Inc.	System and method for providing selective channel sensitivity in an optoacoustic imaging system
US8886294B2 (en)	2011-11-30	2014-11-11	Covidien Lp	Methods and systems for photoacoustic monitoring using indicator dilution
US9131852B2 (en)	2011-12-05	2015-09-15	Covidien Lp	Methods and systems for photoacoustic monitoring using indicator dilution
US9186068B2 (en)	2011-12-05	2015-11-17	Covidien Lp	Methods and systems for photoacoustic monitoring using hypertonic and isotonic indicator dilutions
WO2013134772A2 (en)	2012-03-09	2013-09-12	Seno Medical Instruments, Inc.	Statistical mapping in an optoacoustic imaging system
US8885155B2 (en)	2012-04-30	2014-11-11	Covidien Lp	Combined light source photoacoustic system
BR112015021807A2 (pt)	2013-03-15	2017-07-18	Seno Medical Instr Inc	sistema e método de apoio para classificação de vetor de diagnóstico
US10309936B2 (en)	2013-10-11	2019-06-04	Seno Medical Instruments, Inc.	Systems and methods for component separation in medical imaging
JP6364792B2 (ja)	2014-01-31	2018-08-01	セイコーエプソン株式会社	生体情報処理方法、生体情報処理装置、コンピューターシステム、及びウェアラブル機器
EP3110319A1 (en)	2014-02-27	2017-01-04	Seno Medical Instruments, Inc.	Probe adapted to control blood flow through vessels during imaging and method of use of same
JP6621819B2 (ja)	2014-10-30	2019-12-18	セノメディカルインストルメンツ，インク．	音響波を用いた光源および音響レシーバの相対的な向きの検出を伴う光音響撮像システム
CN106769878B (zh) *	2016-12-12	2023-10-03	福建工程学院	一种基于光声光谱的中药汤剂成分检测方法及装置
EP3761006B1 (en)	2019-07-03	2025-11-05	Nokia Technologies Oy	Photoacoustic apparatus and methods
EP4009035A1 (de) *	2020-12-07	2022-06-08	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Photoakustisches sonar-spektrometer
CN114468991B (zh) *	2021-02-11	2023-01-17	先阳科技有限公司	抖动影响的抑制方法、装置及可穿戴设备
CN120114014A (zh) *	2025-05-13	2025-06-10	浙江大学	多波长光声成像结合深度学习的无创细菌检测方法及装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4281645A (en) *	1977-06-28	1981-08-04	Duke University, Inc.	Method and apparatus for monitoring metabolism in body organs
US4200399A (en) *	1978-11-20	1980-04-29	General Motors Corporation	Resonant optoacoustic spectroscopy apparatus
IL63053A0 (en) *	1981-06-05	1981-09-13	Yeda Res & Dev	Device and method for measurement of photosynthetic activity by photoacoustic spectroscopy
DE3576219D1 (de) *	1984-10-16	1990-04-05	Fuji Photo Film Co Ltd	Akustooptische bildformung.
US4622845A (en) *	1985-03-21	1986-11-18	Westinghouse Electric Corp.	Method and apparatus for the detection and measurement of gases

1988
- 1988-03-01 NO NO880891A patent/NO880891L/no unknown
- 1988-03-02 DK DK111088A patent/DK111088A/da not_active Application Discontinuation
- 1988-03-02 FI FI880969A patent/FI880969A7/fi not_active IP Right Cessation
- 1988-03-02 IL IL85611A patent/IL85611A0/xx unknown
- 1988-03-03 DD DD88313361A patent/DD300132A5/de not_active IP Right Cessation
- 1988-03-03 KR KR1019880002220A patent/KR880011584A/ko not_active Withdrawn
- 1988-03-03 CN CN88101586A patent/CN1032587A/zh active Pending
- 1988-03-03 PL PL27097788A patent/PL270977A1/xx unknown
- 1988-03-03 EP EP88301868A patent/EP0282234A1/en not_active Withdrawn

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102021004609A1 (de)	2021-09-11	2023-03-16	Eques Consulting GmbH	Vorrichtung und damit durchführbares Verfahren zur non-invasiven Konzentrationsbestimmung von Komponenten im menschlichen Blutkreislauf und Verwendung des Verfahrens.

Also Published As

Publication number	Publication date
NO880891L (no)	1988-09-05
NO880891D0 (no)	1988-03-01
KR880011584A (ko)	1988-10-29
FI880969A7 (fi)	1988-09-04
PL270977A1 (en)	1988-12-08
CN1032587A (zh)	1989-04-26
EP0282234A1 (en)	1988-09-14
FI880969A0 (fi)	1988-03-02
DK111088A (da)	1988-10-18
DK111088D0 (da)	1988-03-02
IL85611A0 (en)	1988-08-31

Publication	Publication Date	Title
DD300132A5 (de)	1992-05-21	Einrichtung und verfahren zum nachweisen und messen der konzentration von substanzen in einer probe durch optoakustische spektroskopie
EP2046190B1 (de)	2010-04-07	Messung der glukosekonzentration in pulsierendem blut
DE69737031T2 (de)	2007-04-26	Vorrichtung zur nicht-invasiven bestimmung von blutparametern
DE69032126T2 (de)	1998-10-15	Nicht-invasive messung der glukose im blut
DE69328331T2 (de)	2000-11-30	Reproduzierbare unblutige Messung von Blutgasen
EP0659055B1 (de)	1996-04-10	Verfahren und vorrichtung zur analyse von glucose in einer biologischen matrix
EP0680727B1 (de)	2003-06-18	Analysesystem zur Überwachung der Konzentration eines Analyten im Blut eines Patienten
DE69032535T2 (de)	1998-12-10	Verfahren und Vorrichtung zur Bestimmung der Ähnlichkeit eines biologischen Analyts, ausgehend von einem aus bekannten biologischen Fluiden hergestellten Modell
DE60312737T2 (de)	2007-12-06	Verfahren und Vorrichtung zur Messung von Blutbestandteilen
DE60318323T2 (de)	2009-03-05	Kalibrationstechnik für nichtinvasive medizinische vorrichtungen
DE69127092T2 (de)	1998-02-05	Verfahren und vorrichtung zur bestimmung physiologischer grössen ausgehend von der pupillen-reaktion
DE69227545T2 (de)	1999-04-29	Oximeter zur zuverlässigen klinischen Bestimmung der Blutsauerstoffsättigung in einem Fötus
EP1292220B1 (de)	2006-12-13	Verfahren und vorrichtung zum nachweisen von substanzen in körperflüssigkeiten mittels raman-spektroskopie
AT397458B (de)	1994-04-25	Sensoranordnung
DE69123448T2 (de)	1997-05-22	Eingriffsfreie messung der blutglukose
DE69837425T2 (de)	2007-12-13	Verfahren und Vorrichtung zur nichtinvasiven photoakustischen Messung von Blutglukose
DE69933717T2 (de)	2007-08-23	Optischer Sensor zur in situ Messung von Analyten
DE69432403T2 (de)	2004-02-05	Ambulante aufzeichnung über vorkommen und aktivität von stoffen im verdauungskanal
DE69728525T2 (de)	2005-04-07	Mittels vakuum verbesserter transdermaler flüssigkeitstransport
DE10392210T5 (de)	2004-12-23	Verfahren und Vorrichtung zum Überwachen einer analytischen Konzentration mittels einer Osmose-Differenz-Druckmessung
EP1040788A1 (de)	2000-10-04	Vorrichtung zur quantitativen Bestimmung der örtlichen Verteilung einer Messgrösse
EP3017292B1 (de)	2023-09-06	Vorrichtung und verfahren zur ermittlung der konzentration eines stoffes in einem flexiblen behälter
DE4314835A1 (de)	1994-11-10	Verfahren und Vorrichtung zur Analyse von Glucose in einer biologischen Matrix
EP3610245B1 (de)	2025-09-24	Analysevorrichtung
JPS63247652A (ja)	1988-10-14	光音響分光方法とその装置

Legal Events

Date	Code	Title
1992-05-07	NAB	Public notice for inspection of provisional exclusive patent accord. to par 17/1 dd-patg.
1992-05-21	A5	Published as prov. exclusive patent
1996-01-18	ENJ	Ceased due to non-payment of renewal fee

DD300132A5 - Einrichtung und verfahren zum nachweisen und messen der konzentration von substanzen in einer probe durch optoakustische spektroskopie - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (2)

Publications (1)

Family

ID=25636014

Family Applications (1)

Country Status (9)

Cited By (1)

Families Citing this family (75)

Family Cites Families (5)

Cited By (1)

Also Published As

Similar Documents

Legal Events